CVS joins West Virginia pseudoephedrine fight

Share this article:

National drugstore chain CVS will no longer sell over-the-counter pseudoephedrine-only medications in West Virginia. The Wall Street Journal reports that the Woonsocket, RI, company is joining peers including Rite Aid and Walgreen Co. which have implemented similar policies in the Appalachian state to dampen local methamphetamine abuse.

Lab runners use pseudoephedrine-only medications, like Sudafed, to make methamphetamine. Stores throughout the US have also attempted to tamp down on abuse by capping the number of units a customer can buy at a time, or by placing the OTC medications behind pharmacy counters (and sometimes requiring ID) to make purchasing more difficult. West Virginia is home to an increasing number of meth labs.

Sudafed manufacturer Johnson & Johnson tells the WSJ it is working with state officials to help control sales of the drug while still keeping it accessible for consumers.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.